Walking and Thinking - Brain Activity During Complex Walking in Aging and Parkinson's Disease
NCT ID: NCT05218213
Last Updated: 2024-10-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
133 participants
OBSERVATIONAL
2022-01-21
2023-06-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The challenge of improving treatments of motor-cognitive difficulties (such as dual-tasking and navigation) is daunting, and an important step is arriving at a method that accurately portrays these impairments in an ecological valid state. The investigators aim therefore to explore brain function during complex walking in healthy and PD by investigating the effects of age and neurological disease on motor-cognitive performance and its neural correlates during three conditions of complex walking (dual-task walking, navigation and a combination of both) using non-invasive measures of brain activity (functional near infrared spectrometry, fNIRS) and advanced gait analysis in real time in young, older healthy adults and people with PD.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brain Activity During Complex Walking in People With Atypical Parkinsonian Syndromes
NCT06906276
Movement Improves Brain Health and Cognition in Parkinson's Disease
NCT07299279
The Effects of 24-Weeks Community-based Brisk Walking in People With Parkinson's Disease
NCT06707402
Brain Activity, Cognitive Function, and Walking Ability in Parkinson's Disease
NCT06588920
Effect of Stimulus Rate on Cognitive and Motor Activity in Young Subjects, Elderly Subjects, and Patients With Parkinson's Disease
NCT00026598
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy young
Healthy young adults
No intervention
Assessment of brain activity with fNIRS and behavioural assessments (motor, motor-cognitive and cognitive) during three complex walking conditions.
1. Dual-task walking with the auditory stroop task.
2. Navigational walking - a course consisting of a distribution of 45 and 90 degrees turns to the left and right
3. Navigational and dual-task walking (condition 1 and 2 together)
Healthy elderly
Healthy elderly adults
No intervention
Assessment of brain activity with fNIRS and behavioural assessments (motor, motor-cognitive and cognitive) during three complex walking conditions.
1. Dual-task walking with the auditory stroop task.
2. Navigational walking - a course consisting of a distribution of 45 and 90 degrees turns to the left and right
3. Navigational and dual-task walking (condition 1 and 2 together)
Parkinson's disease
Elderly with Parkinson's disease
No intervention
Assessment of brain activity with fNIRS and behavioural assessments (motor, motor-cognitive and cognitive) during three complex walking conditions.
1. Dual-task walking with the auditory stroop task.
2. Navigational walking - a course consisting of a distribution of 45 and 90 degrees turns to the left and right
3. Navigational and dual-task walking (condition 1 and 2 together)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
Assessment of brain activity with fNIRS and behavioural assessments (motor, motor-cognitive and cognitive) during three complex walking conditions.
1. Dual-task walking with the auditory stroop task.
2. Navigational walking - a course consisting of a distribution of 45 and 90 degrees turns to the left and right
3. Navigational and dual-task walking (condition 1 and 2 together)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ≥60 years of age,
* 23 or more on the Montreal Cognitive Assessment (MoCA)
* ≥60 years of age
* a clinical diagnosis of PD≤6 months prior to enrollment
* with the ability to walk without a mobility device for ≤5 minutes continuously.
Exclusion Criteria
* Severe hearing or visual impairments that affects participation in the assessments
Healthy elderly:
* Disease or condition that affects gait or balance.
* Severe hearing or visual impairments that affects participation in the assessments
Parkinson cohort:
* People with speech difficulties (e.g. aphasia)
* cognitive difficulties affecting the ability to understand and/or follow verbal/written - instructions
* severe freezing of gait
* Severe hearing or visual impairments that affects participation in the assessments
* Other neurological diseases
* Other disease that can affect gait or balance.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karolinska University Hospital
OTHER
Karolinska Institutet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Erika Franzén
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Erika Franzén, PhD
Role: PRINCIPAL_INVESTIGATOR
Karollinska Institutet
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Karolinska institutet
Stockholm, Solna, Sweden
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Related Links
Access external resources that provide additional context or updates about the study.
ParkMOVE OSF page
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-03059
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.